1.2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome
Yonghoon CHOI ; Young Hoon YOUN ; Seung Joo KANG ; Jeong Eun SHIN ; Young Sin CHO ; Yoon Suk JUNG ; Seung Yong SHIN ; Cheal Wung HUH ; Yoo Jin LEE ; Hoon Sup KOO ; Kwangwoo NAM ; Hong Sub LEE ; Dong Hyun KIM ; Ye Hyun PARK ; Min Cheol KIM ; Hyo Yeop SONG ; Sung-Hoon YOON ; Sang Yeol LEE ; Miyoung CHOI ; Moo-In PARK ; In-Kyung SUNG ;
Journal of Neurogastroenterology and Motility 2025;31(2):133-169
Irritable bowel syndrome (IBS) is a chronic, disabling, and functional bowel disorder that significantly affects social functioning and reduces quality of life and increases social costs. The Korean Society of Neurogastroenterology and Motility published clinical practice guidelines on the management of IBS based on a systematic review of the literature in 2017, and planned to revise these guidelines in light of new evidence on the pathophysiology, diagnosis, and management of IBS. The current revised version of the guidelines is consistent with the previous version and targets adults diagnosed with or suspected of having IBS. These guidelines were developed using a combination of de novo and adaptation methods, with analyses of existing guidelines and discussions within the committee, leading to the identification of key clinical questions. Finally, the guidelines consisted of 22 recommendations, including 3 concerning the definition and risk factors of IBS, 4 regarding diagnostic modalities and strategies, 2 regarding general management, and 13 regarding medical treatment. For each statement, the advantages, disadvantages, and precautions were thoroughly detailed. The modified Delphi method was used to achieve expert consensus to adopt the core recommendations of the guidelines. These guidelines serve as a reference for clinicians (including primary care physicians, general healthcare providers, medical students, residents, and other healthcare professionals) and patients, helping them to make informed decisions regarding IBS management.
2.2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome
Yonghoon CHOI ; Young Hoon YOUN ; Seung Joo KANG ; Jeong Eun SHIN ; Young Sin CHO ; Yoon Suk JUNG ; Seung Yong SHIN ; Cheal Wung HUH ; Yoo Jin LEE ; Hoon Sup KOO ; Kwangwoo NAM ; Hong Sub LEE ; Dong Hyun KIM ; Ye Hyun PARK ; Min Cheol KIM ; Hyo Yeop SONG ; Sung-Hoon YOON ; Sang Yeol LEE ; Miyoung CHOI ; Moo-In PARK ; In-Kyung SUNG ;
Journal of Neurogastroenterology and Motility 2025;31(2):133-169
Irritable bowel syndrome (IBS) is a chronic, disabling, and functional bowel disorder that significantly affects social functioning and reduces quality of life and increases social costs. The Korean Society of Neurogastroenterology and Motility published clinical practice guidelines on the management of IBS based on a systematic review of the literature in 2017, and planned to revise these guidelines in light of new evidence on the pathophysiology, diagnosis, and management of IBS. The current revised version of the guidelines is consistent with the previous version and targets adults diagnosed with or suspected of having IBS. These guidelines were developed using a combination of de novo and adaptation methods, with analyses of existing guidelines and discussions within the committee, leading to the identification of key clinical questions. Finally, the guidelines consisted of 22 recommendations, including 3 concerning the definition and risk factors of IBS, 4 regarding diagnostic modalities and strategies, 2 regarding general management, and 13 regarding medical treatment. For each statement, the advantages, disadvantages, and precautions were thoroughly detailed. The modified Delphi method was used to achieve expert consensus to adopt the core recommendations of the guidelines. These guidelines serve as a reference for clinicians (including primary care physicians, general healthcare providers, medical students, residents, and other healthcare professionals) and patients, helping them to make informed decisions regarding IBS management.
3.2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome
Yonghoon CHOI ; Young Hoon YOUN ; Seung Joo KANG ; Jeong Eun SHIN ; Young Sin CHO ; Yoon Suk JUNG ; Seung Yong SHIN ; Cheal Wung HUH ; Yoo Jin LEE ; Hoon Sup KOO ; Kwangwoo NAM ; Hong Sub LEE ; Dong Hyun KIM ; Ye Hyun PARK ; Min Cheol KIM ; Hyo Yeop SONG ; Sung-Hoon YOON ; Sang Yeol LEE ; Miyoung CHOI ; Moo-In PARK ; In-Kyung SUNG ;
Journal of Neurogastroenterology and Motility 2025;31(2):133-169
Irritable bowel syndrome (IBS) is a chronic, disabling, and functional bowel disorder that significantly affects social functioning and reduces quality of life and increases social costs. The Korean Society of Neurogastroenterology and Motility published clinical practice guidelines on the management of IBS based on a systematic review of the literature in 2017, and planned to revise these guidelines in light of new evidence on the pathophysiology, diagnosis, and management of IBS. The current revised version of the guidelines is consistent with the previous version and targets adults diagnosed with or suspected of having IBS. These guidelines were developed using a combination of de novo and adaptation methods, with analyses of existing guidelines and discussions within the committee, leading to the identification of key clinical questions. Finally, the guidelines consisted of 22 recommendations, including 3 concerning the definition and risk factors of IBS, 4 regarding diagnostic modalities and strategies, 2 regarding general management, and 13 regarding medical treatment. For each statement, the advantages, disadvantages, and precautions were thoroughly detailed. The modified Delphi method was used to achieve expert consensus to adopt the core recommendations of the guidelines. These guidelines serve as a reference for clinicians (including primary care physicians, general healthcare providers, medical students, residents, and other healthcare professionals) and patients, helping them to make informed decisions regarding IBS management.
4.Neurologic complications in patients with carotid artery stenting
Na Young KIM ; Jong Wook CHOI ; Kum WHANG ; Sung Min CHO ; Youn Moo KOO ; Jong Yeon KIM
Journal of Cerebrovascular and Endovascular Neurosurgery 2019;21(2):86-93
OBJECTIVE: Carotid artery stenting is helpful in patients with carotid artery stenosis and is a common method of treatment. However, data on the neurological consequences that might arise from, especially Asian patients after CAS is not enough. The purpose of this study was to investigate the outcome and prognostic factors affecting CAS patients.METHODS: From January 2013 to June 2018 it was enrolled 97 patients who underwent CAS with severe carotid artery stenosis in a single institution. We retrospectively reviewed neurologic complications such as restenosis, ipsilateral or contralateral stroke, and hyperperfusion during the 6-month follow-up period.RESULTS: There were no complication occured during the procedure in all 97 patients. Neurologic complications occurred in 30 patients (30.9%) after the procedure, and ipsilateral stroke 6 (6.2%), contralateral stroke 9 (9.4%), restenosis 2 (2.1%) and hyperperfusion 13 respectively. One of them had died (1.0%), of which the rest were discharged after symptoms improve. On univariate analysis, DM and pre-op NIHSS score was associated with the risk of CAS complication, exclusively. On the binary logistic regression for risk factors, DM (OR 0.144, 95% CI [0.029–0.718]), history of radiotheraphy (OR 36.103, 95% CI [1.009–1291.789]) and preoperative NIHSS (OR 1.266, 95% CI [1.059–1.513]) showed independent risk factors associated with post procedural neurological complications, statistically.CONCLUSION: Carotid artery stenting is a relatively safe and reliable long-term outcome for patients with carotid artery stenosis. However, careful observation should be taken after procedure immediately for any possible complications.
Asian Continental Ancestry Group
;
Carotid Arteries
;
Carotid Stenosis
;
Endovascular Procedures
;
Follow-Up Studies
;
Humans
;
Logistic Models
;
Methods
;
Postoperative Complications
;
Retrospective Studies
;
Risk Factors
;
Stents
;
Stroke
5.The Risk Factors of Subdural Hygroma after Decompressive Craniectomy.
Byeong Oh KIM ; Jong Yeon KIM ; Kum WHANG ; Sung Min CHO ; Ji Woong OH ; Youn Moo KOO ; Chul HU ; Jin Soo PYEN ; Jong Wook CHOI
Korean Journal of Neurotrauma 2018;14(2):93-98
OBJECTIVE: Subdural effusion, also known as subdural hygroma (SDG), is a secondary complication that can occur after decompressive craniectomy (DC). However, the pathogenesis of SDG is not fully understood. It is unclear whether SDG occurrence is related to preoperative patient status or surgical technique. The purpose of this study is to identify risk factors for SDG after DC. METHODS: Fifty-nine patients who underwent DC from January 2016 to December 2016 at the same institution were analyzed. We retrospectively reviewed the clinical and radiological features of the patients. We divided the patients into two groups based on the occurrence of SDG after DC. The risk factors for SDG were analyzed. RESULTS: The overall SDG rate after DC was 39% (23 patients). A statistically significant association was observed between preoperative diagnosis, e.g., subdural hemorrhage (SDH; odds ratio [OR], 4.99; 95% confidence interval [CI], 1.36–18.34) or subarachnoid hemorrhage (SAH; OR, 4.18; 95% CI, 1.07–16.32), and the occurrence of SDG after DC. Traumatic brain injury (OR, 4.91; 95% CI, 1.35–17.91) and preoperative cortical opening (OR, 4.77; 95% CI, 1.39–16.32) were important risk factors for SDG. Several surgical techniques did not show a statistically significant association with SDG. The occurrence of SDG after DC was related to the length of hospital stay (p=0.012), but not to prognosis. CONCLUSION: After DC, SDG is not related to patients' prognosis but to the length of hospital stay. Therefore, it is necessary to study the occurrence of postoperative SDG by confirming the presence of preoperative SDH, SAH, and cortical opening.
Brain Injuries
;
Decompressive Craniectomy*
;
Diagnosis
;
Hematoma, Subdural
;
Humans
;
Length of Stay
;
Odds Ratio
;
Prognosis
;
Retrospective Studies
;
Risk Factors*
;
Subarachnoid Hemorrhage
;
Subdural Effusion*
6.Periodontal pathogens and the association between periodontitis and rheumatoid arthritis in Korean adults
Jin Hee KIM ; In Ah CHOI ; Joo Youn LEE ; Kyoung Hwa KIM ; Sungtae KIM ; Ki Tae KOO ; Tae Il KIM ; Yang Jo SEOL ; Young KU ; In Chul RHYU ; Yeong Wook SONG ; Yong Moo LEE
Journal of Periodontal & Implant Science 2018;48(6):347-359
PURPOSE: Periodontitis and rheumatoid arthritis (RA) share a similar inflammatory pathogenesis. Porphyromonas gingivalis (Pg) can induce anticyclic-citrullinated peptide autoantibodies (anti-CCP antibodies), a key factor in the development of RA. This study aimed at evaluating the relationships between the 2 diseases and identifying the clinical implications thereof, with a focus on periodontal pathogens in Korean adults. METHODS: A total of 260 RA patients and 86 age- and sex-matched control patients without arthritis were enrolled in this prospective cross-sectional study. Periodontal indices and the prevalence and amount of periodontal pathogens were compared between the groups. Correlations between periodontal and RA indices were examined, as were correlations between 9 periodontal pathogens and RA indices. RESULTS: The RA group had significantly higher values than the control group for all investigated periodontal indices (P < 0.05) except the number of teeth. The gingival index (GI) was correlated with the disease activity score 28 (DAS28) (r = 0.125, P = 0.049), RA disease duration (r = 0.253, P < 0.001), erythrocyte sedimentation rate (ESR) (r = 0.162, P = 0.010), and anti-CCP antibody titer (r = 0.205, P = 0.004). Probing pocket depth (PPD) was correlated with ESR (r = 0.139, P = 0.027) and anti-Pg antibody titer (r = 0.203, P = 0.001). Bleeding on probing (BOP) was correlated with DAS28 (r = 0.137, P = 0.030), RA disease duration (r = 0.202, P = 0.001), ESR (r = 0.136, P = 0.030), anti-Pg antibody titer (r = 0.177, P = 0.005), and anti-CCP antibody titer (r = 0.188, P = 0.007). Clinical attachment level (CAL) and periodontitis severity were correlated with anti-Pg antibody titer (the former r = 0.201, P = 0.002; the latter r = 0.175, P = 0.006). The quantity of Pg was positively correlated with the serum anti-Pg antibody titer (r = 0.148, P = 0.020). CONCLUSIONS: The GI, BOP, and PPD showed positive relationships with several RA indices. The anti-Pg antibody titer had positive relationships with PPD, BOP, CAL, and periodontitis severity. Thus, increasing values of periodontal indices could be used as a risk indicator of disease development in RA patients, and an increasing anti-Pg antibody titer could be considered as a warning sign in RA patients suffering with periodontitis.
Adult
;
Arthritis
;
Arthritis, Rheumatoid
;
Autoantibodies
;
Blood Sedimentation
;
Cross-Sectional Studies
;
Hemorrhage
;
Humans
;
Periodontal Index
;
Periodontitis
;
Porphyromonas gingivalis
;
Prevalence
;
Prospective Studies
;
Tooth
7.Factors Affecting Optimal Time of Cranioplasty: Brain Sunken Ratio.
Jong Min LEE ; Kum WHANG ; Sung Min CHO ; Jong Yeon KIM ; Ji Woong OH ; Youn Moo KOO ; Chul HU ; Jin Soo PYEN ; Jong Wook CHOI
Korean Journal of Neurotrauma 2017;13(2):113-118
OBJECTIVE: After a rigorous management of increased intracranial pressure by decompressive craniectomy (DC), cranioplasty (CP) is usually carried out for functional and cosmetic purposes. However, the optimal timing of CP remains controversial. Our study aims to analyze the relationship between the optimal timing of CP and the post-operative complications. METHODS: From January 2013 to December 2015, ninety patients who underwent CP in a single institution were analyzed. We set the independent variables as follows: 1) patient characteristics; 2) the time interval between the DC and CP; 3) operation time; 4) anesthesia time; and 5) pre-operative computed tomography (CT) findings such as a degree of sunken brain by ratio of A (the median length from scalp to midline) to B (the length from midline to inner table of skull at this level). The dependent variables of this study are the event of post-operative complications. RESULTS: The overall complication rate was 33.3%. There was no statistical significance in the time interval between the DC and CP in the groups with and without complications of CP (p=0.632). However, there was a significant statistical difference in the degree of sunken brain by ratio (A/B) between the two groups (p<0.001). CONCLUSION: From this study, we conclude that it is better to determine the optimal timing of CP by the pre-operative CT finding than by the time interval between the DC and CP. Hereby, we suggest a potentially useful determinant of optimal timing of CP.
Anesthesia
;
Brain*
;
Decompressive Craniectomy
;
Humans
;
Intracranial Pressure
;
Scalp
;
Skull
8.Cranial Nerve Palsy after Onyx Embolization as a Treatment for Cerebral Vascular Malformation.
Jong Min LEE ; Kum WHANG ; Sung Min CHO ; Jong Yeon KIM ; Ji Woong OH ; Youn Moo KOO ; Chul HU ; Jinsoo PYEN ; Jong Wook CHOI
Journal of Cerebrovascular and Endovascular Neurosurgery 2017;19(3):189-195
The Onyx liquid embolic system is a relatively safe and commonly used treatment for vascular malformations, such as arteriovenous fistulas and arteriovenous malformations. However, studies on possible complications after Onyx embolization in patients with vascular malformations are limited, and the occurrence of cranial nerve palsy is occasionally reported. Here we report the progress of two different types of cranial nerve palsy that can occur after embolization. In both cases, Onyx embolization was performed to treat vascular malformations and ipsilateral oculomotor and facial nerve palsies were observed. Both patients were treated with steroids and exhibited symptom improvement after several months. The most common types of neuropathy that can occur after Onyx embolization are facial nerve palsy and trigeminal neuralgia. Although the mechanisms underlying these neuropathies are not clear, they may involve traction injuries sustained while extracting the microcatheter, mass effects resulting from thrombi and edema, or Onyx reflux into the vasa nervorum. In most cases, the neuropathy spontaneously resolves several months following the procedure.
Arteriovenous Fistula
;
Arteriovenous Malformations
;
Cranial Nerve Diseases*
;
Cranial Nerves*
;
Edema
;
Facial Nerve
;
Humans
;
Paralysis
;
Steroids
;
Traction
;
Trigeminal Neuralgia
;
Vasa Nervorum
;
Vascular Malformations*
9.Endovascular Treatment of Giant Serpentine Aneurysm of the Middle Cerebral Artery.
Young Ha JEONG ; Jong Yeon KIM ; Youn Moo KOO ; Jong Wook CHOI ; Kum WHANG ; Chul HU ; Sung Min CHO
Journal of Cerebrovascular and Endovascular Neurosurgery 2016;18(3):264-270
Giant serpentine aneurysms are uncommon types of aneurysmal disease and have angiographically authentic features. We report a case of a 44-year-old male with headache and seizure. He presented a giant serpentine aneurysm arising from the middle cerebral artery (MCA). It was a large intracranial aneurysm thrombosed as a mass-like lesion while it maintained its outflow drainage into the distal MCA branches. The balloon occlusion test (BOT) was performed to test the tolerance of temporary collateral circulation. Following routine cerebral angiography, we performed an endovascular embolization on the proximal artery of MCA. He was discharged from the hospital with alert mental status and mild Gerstmann syndrome. The short-term follow-up imaging studies showed the decreased mass effect, and the patient presented an improved Gerstmann syndrome. After a careful evaluation of BOT, an endovascular embolization can be one of the powerful therapeutic instruments for giant serpentine aneurysm.
Adult
;
Aneurysm*
;
Arteries
;
Balloon Occlusion
;
Cerebral Angiography
;
Collateral Circulation
;
Drainage
;
Follow-Up Studies
;
Gerstmann Syndrome
;
Headache
;
Humans
;
Intracranial Aneurysm
;
Male
;
Middle Cerebral Artery*
;
Seizures
10.Changing Korean Menopausal Women's Awareness on Hormone Therapy: 7-years after Women's Health Initiative Study.
Youn Jee CHUNG ; Mee Ran KIM ; Hye Won JEONG ; Byung Koo YOON ; Byung Suk LEE ; Byung Moon KANG ; Hoon CHOI ; Hyoung Moo PARK ; Jung Gu KIM
The Journal of Korean Society of Menopause 2012;18(2):94-99
OBJECTIVES: The purpose of this survey was to compare Korean menopausal women's perceptions of hormone replacement therapy before and after publication of the Women's Health Initiative (WHI) study. METHODS: This study was conducted through a survey of 713 postmenopausal women, who attended lectures on health to commemorate Korean Menopause Awareness Month, during 2009 in Seoul and the provinces (Incheon, Daejeon, Daegu, Gwangju and Busan). RESULTS: Respondents' knowledge concerning the cause of menopause have been increased to 86.7% in 2009, compared to 56.6% in 2002. Women who required hormone therapy increased to 57.6% in 2009, compared to 56.6% in 2002. As a source of information about hormone therapy, media was about 34.0% in 2009, different from the previous study that doctor's advice was 60.7%. Among the women who stopped hormone therapy, the most common reason was fear of cancer (31.8%), which increased compared to 9.3% in 2002. Women who received regular screening for breast cancer increased to 82.3% in 2009, compared to 35.0% in 2002. Women who checked bone mineral density (BMD) increased to 71.8% in 2009, compared to 40.2% in 2002. CONCLUSION: Menopausal women in Korea have increased their awareness of menopause. They responded that hormone therapy was helpful to manage menopausal symptoms, even after WHI study. They obtained menopause-related information through various sources, and the role of mass media has been greatly increased. But they were concerned about the increased risk for cancer, especially breast cancer.
Bone Density
;
Breast Neoplasms
;
Female
;
Hormone Replacement Therapy
;
Humans
;
Korea
;
Lectures
;
Mass Media
;
Mass Screening
;
Menopause
;
Publications
;
Republic of Korea
;
Women's Health

Result Analysis
Print
Save
E-mail